The massive insider buying cluster on May 11, 2026, with $5.9M in open-market purchases by a director and CFO, is a strong bullish signal. Traders should watch for a potential catalyst (e.g., upcoming earnings, product approval, or M&A) that insiders may be anticipating. The $150K purchases by Mead and Leavitt are confirmatory but not material on their own.
Price Chart
Executive Summary
Two insiders at Mobia Medical made small open-market purchases totaling $150K on May 11, 2026, at $15/share. This follows a much larger cluster on the same day where a director and the CFO converted derivatives and made substantial open-market buys ($5.9M total), signaling strong insider conviction. The $150K is trivial relative to the company's market cap and likely routine, but the broader cluster context is highly bullish.
Key Financial Metrics
Key Facts
- Two insiders (Director Mead and Officer Leavitt) purchased 10,000 shares total for $150K at $15/share on May 11, 2026.
- This cluster is part of a larger 20-trade insider cluster on May 11, 2026, where Director Harrington bought $4M open-market and CFO Curnes converted derivatives and had tax withholding.
- The broader cluster includes $5.9M in open-market purchases by Harrington and Director Lucchese, plus derivative conversions by multiple insiders.
- Cross-filing actuarial verdicts show all rule pairs are AMPLIFIERS, supporting an elevated impact score.
- The $150K in this specific cluster is 0.05% of a $326M market cap, but the aggregate insider buying ($5.9M) is 1.8% of market cap, highly material.
Financial Impact
Total insider open-market purchases in the broader cluster: $5,925,000 (1.8% of market cap). This specific cluster: $150,000 (0.05% of market cap).
Risk Factors
- Insider buying may be pre-planned or part of a compensation program, not necessarily signaling near-term upside.
- The company's market cap is small ($326M), making large insider buys potentially less informative than at larger firms.
- No specific catalyst is identified in the filing; the buying could be based on long-term conviction rather than imminent news.
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-MOBI-1778549828360 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 11d ago | 8-K/A | $8.81 | awaiting T+60 | — | $11.14 (+26.45%) |
Oct 15, 2026 12d ago | Press Release | $8.09 | awaiting T+60 | — | $11.14 (+37.70%) |
Aug 20, 2026 9w ago | Insider Buy | $10.61 | awaiting T+60 | — | $11.14 (+5.00%) |
Aug 17, 2026 10w ago | Insider Buy | $11.73 | awaiting T+60 | — | $11.14 (−5.03%) |
Jun 29, 2026 17w ago | Insider Cluster | $13.40 $9.16 | ▼ −31.64% | ▼ −34.46% | $11.14 (−16.87%) |
Jun 11, 2026 19w ago | Insider Buy | $12.31 $11.09 | ▼ −9.91% | ▼ −13.17% | $11.14 (−9.50%) |
May 11, 2026 24w ago | Insider Cluster | $12.00 $12.25 | ▲ +2.08% | ▼ −2.31% | $11.14 (−7.17%) |
May 11, 2026 24w ago | Insider Cluster | $12.00 $12.25 | ▲ +2.08% | ▼ −2.31% | $11.14 (−7.17%) |
May 8, 2026 24w ago | EFFECT | $11.75 $11.84 | ▲ +0.77% | ▼ −4.07% | $11.14 (−5.19%) |
May 7, 2026 24w ago | 3 | $11.75 $11.84 | ▲ +0.77% | ▼ −4.07% | $11.14 (−5.19%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers